Sign In
Buy TTOO
$0.0020
+0 (+0%)
At Close: Jun 03, 2026
T2 Biosystems to Attend Upcoming Investor Conferences
04:05pm, Thursday, 01'st Aug 2024
LEXINGTON, Mass., Aug. 01, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced pla
T2 Biosystems, Inc. (TTOO) Q2 2024 Earnings Call Transcript
06:36pm, Monday, 29'th Jul 2024
T2 Biosystems, Inc. (NASDAQ:TTOO ) Q2 2024 Earnings Conference Call July 29, 2024 4:30 PM ET Company Participants Trip Taylor - Investor Relations John Sperzel - Chairman & Chief Executive Officer Joh
T2 Biosystems Announces Commercial Expansion Through Malaysia and Indonesia Distributor
04:02pm, Monday, 29'th Jul 2024
LEXINGTON, Mass., July 29, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, today announced the e
T2 Biosystems to Report Second Quarter 2024 Financial Results and Business Updates on July 29, 2024
04:05pm, Monday, 22'nd Jul 2024
LEXINGTON, Mass., July 22, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today tha
T2 Biosystems Regains Compliance with Nasdaq Continued Listing Requirements
09:00am, Wednesday, 22'nd May 2024
LEXINGTON, Mass., May 22, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, t
T2 Biosystems Announces Closing of $8 Million Private Placement Priced At-The-Market Under Nasdaq Rules
04:05pm, Friday, 17'th May 2024
LEXINGTON, Mass., May 17, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that
T2 Biosystems Announces $8 Million Private Placement Priced At-The-Market Under Nasdaq Rules
07:00am, Wednesday, 15'th May 2024
LEXINGTON, Mass., May 15, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that
T2 Biosystems Announces CRG's Conversion from Preferred Stock to Common Stock
05:00pm, Tuesday, 14'th May 2024
LEXINGTON, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, t
T2 Biosystems Announces Letter of Intent to Enter Strategic Partnership for Lyme Disease
09:00am, Tuesday, 07'th May 2024
Advances plan to launch T2Lyme Panel for detection of early Lyme disease Advances plan to launch T2Lyme Panel for detection of early Lyme disease
T2 Biosystems, Inc. (TTOO) Q1 2024 Earnings Call Transcript
11:43pm, Monday, 06'th May 2024
T2 Biosystems, Inc. (NASDAQ:TTOO ) Q1 2024 Earnings Conference Call May 6, 2024 4:30 PM ET Company Participants Philip Taylor - IR, Gilmartin Group John Sperzel - Chairman & CEO John Sprague - CFO Con
T2 Biosystems Announces Commercial Expansion Through Middle East Distributor
04:34pm, Monday, 06'th May 2024
Filed Pursuant to Rule 433 Issuer Free Writing Prospectus dated May 6, 2024 Relating to Preliminary Prospectus dated May 6, 2024 Registration No. 333-278866 LEXINGTON, Mass.
T2 Biosystems Announces First Quarter 2024 Financial Results
04:34pm, Monday, 06'th May 2024
Achieved double-digit growth in sepsis product revenue and reduced debt by approximately 80% compared to the prior year period Achieved double-digit growth in sepsis product revenue and reduced debt b
T2 Biosystems Announces the Conversion of an Additional $15 Million of CRG Term Loan into Equity
04:29pm, Monday, 06'th May 2024
Strengthens balance sheet by reducing total debt by approximately 80% over the past year Strengthens balance sheet by reducing total debt by approximately 80% over the past year
T2 Biosystems to Report First Quarter 2024 Financial Results and Business Updates on May 6, 2024
09:00am, Wednesday, 24'th Apr 2024
LEXINGTON, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today th
T2 Biosystems Shareholders Vote for CRG Debt Conversion into Equity
04:05pm, Thursday, 11'th Apr 2024
LEXINGTON, Mass., April 11, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced res
